The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Association of efficacy and adverse events of special interest of avelumab in the JAVELIN solid tumor and JAVELIN Merkel 200 trials.
 
Karen Kelly
Honoraria - Merck
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; G1 Therapeutics; Genentech/Roche; Janssen; Lilly; Regeneron
Research Funding - Abbvie (Inst); Celgene (Inst); EMD Serono (Inst); Five Prime Therapeutics (Inst); Genentech (Inst); Lilly (Inst); Lycera (Inst); Novartis (Inst); Regeneron (Inst); Transgene (Inst)
Patents, Royalties, Other Intellectual Property - Author Royalties for UpToDate, an evidence based, peer reviewed information resource, available via the web, desktop, and PDA.
Travel, Accommodations, Expenses - ARIAD; AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Lilly; Merck; Regeneron
 
Juliane Manitz
Employment - EMD Serono
 
Manish R. Patel
Speakers' Bureau - Celgene; Exelixis; Genentech/Roche; Taiho Pharmaceutical
 
Anja H. Loos
Employment - Merck KGaA
Patents, Royalties, Other Intellectual Property - Merck KGaA
 
Arthur Allignol
Employment - Merck KGaA
 
Vikram K. Chand
Employment - EMD Serono
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Vijay Kasturi
Employment - EMD Serono
 
Kevin M. Chin
Employment - EMD Serono
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
John Warth
Employment - EMD Serono
 
Hao Zhang
Employment - EMD Serono
 
Anja von Heydebreck
Employment - Merck KGaA
Stock and Other Ownership Interests - Merck KGaA
 
James L. Gulley
Research Funding - Astellas Medivation (Inst); Bavarian Nordic (Inst); EMD Serono (Inst); NantBioScience (Inst); Pfizer (Inst)